Company · CIK 0001262104 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Lite Strategy, Inc. · LITS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 PForm 4 → | Jun 25, 4:30 pm EDT | James P FlynnDirector | 25,000 | $0.8555 | $21,388 | 125,000 | +25.0% | |
| Aug 7, 2018 SForm 4 → | Aug 8, 6:01 pm EDT | David M UrsoChief Operating Officer & GC | 9,500 | $3.58 | $34,044 | 24,106 | −28.3% | plan? |
| Aug 6, 2018 FForm 4/A → | Sep 6, 8:20 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 50,938 | $3.75 | $191,018 | 322,882 | — | plan? |
| Aug 6, 2018 FForm 4 → | Aug 8, 6:01 pm EDT | David M UrsoChief Operating Officer & GC | 17,764 | $3.75 | $66,615 | 33,606 | — | plan? |
| Aug 6, 2018 FForm 4 → | Aug 8, 6:00 pm EDT | Robert D. MassChief Medical Officer | 17,709 | $3.75 | $66,409 | 33,661 | — | plan? |
| Aug 6, 2018 FForm 4 → | Aug 8, 5:59 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 54,093 | $3.75 | $202,849 | 319,727 | — | plan? amended |
| Mar 29, 2018 FForm 4 → | Mar 30, 2:14 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 128,920 | $2.07 | $266,864 | 271,080 | — | plan? |
| Nov 27, 2017 PForm 4 → | Nov 29, 6:39 pm EST | Charles V. Baltic IIIDirector | 11,000 | $2.25 | $24,801 | 24,250 | +83.0% | plan? |
| Nov 27, 2017 SForm 4 → | Nov 29, 6:39 pm EST | Charles V. Baltic IIIDirector | 11,000 | $2.21 | $24,272 | 13,250 | −45.4% | plan? |
| Nov 5, 2015 SForm 4 → | Nov 9, 8:09 pm EST | VIVO VENTURES VII, LLC10% Owner | 390,572 | $1.84 | $720,363 | 3,163,105 | −11.0% | plan? |
| Nov 5, 2015 SForm 4 → | Nov 9, 8:09 pm EST | Vivo Ventures V, LLC10% Owner | 22,693 | $1.84 | $41,855 | 183,767 | −11.0% | plan? |
| Mar 24, 2015 SForm 4 → | Mar 26, 4:54 pm EDT | New Leaf Ventures II, L.P. +710% Owner | 1,601,390 | $1.97 | $3,160,183 | 0 | −100% | plan? |
| Mar 24, 2015 OForm 4 → | Mar 26, 3:02 pm EDT | VIVO VENTURES VII, LLC10% Owner | 455,174 | $3.12 | $1,420,143 | 3,553,677 | — | plan? |
| Mar 24, 2015 OForm 4 → | Mar 26, 3:00 pm EDT | Vivo Ventures V, LLC10% Owner | 26,445 | $3.12 | $82,508 | 206,460 | — | plan? |
| Jan 21, 2015 PForm 4 → | Jan 23, 12:11 pm EST | Charles V. Baltic IIIDirector | 5,000 | $3.81 | $19,050 | 24,250 | +26.0% | plan? |
| Dec 31, 2014 PForm 4 → | Jan 2, 2015, 3:40 pm EST | Charles V. Baltic IIIDirector | 3,000 | $4.27 | $12,810 | 5,350 | +128% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2018 AForm 4 → | Jul 16, 5:35 pm EDT | David M UrsoChief Operating Officer & GC | 220,000 | — | — | 220,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:34 pm EDT | Robert D. MassChief Medical Officer | 130,000 | — | — | 130,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:33 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 300,000 | — | — | 300,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:32 pm EDT | Brian G. DrazbaChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:30 pm EDT | Christine Anna WhiteDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:29 pm EDT | William Dodge RueckertDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:28 pm EDT | Thomas C ReynoldsDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:27 pm EDT | Nicholas GloverDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:26 pm EDT | Frederick W DriscollDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:25 pm EDT | Kevan ClemensDirector | 40,000 | — | — | 40,000 | — | |
| Jul 12, 2018 AForm 4 → | Jul 16, 5:24 pm EDT | Charles V. Baltic IIIDirector | 40,000 | — | — | 40,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 26, 2:33 pm EDT | Brian G. DrazbaChief Financial Officer | 130,000 | — | — | 130,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 26, 2:27 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 380,000 | — | — | 380,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 26, 2:27 pm EDT | Robert D. MassChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Jun 22, 2018 AForm 4 → | Jun 26, 2:27 pm EDT | David M UrsoSr. V.P. and General Counsel | 130,000 | — | — | 130,000 | — | |
| Feb 22, 2018 AForm 4 → | Feb 26, 1:12 pm EST | Frederick W DriscollDirector | 33,333 | — | — | 33,333 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:56 pm EDT | Christine Anna WhiteDirector | 40,000 | — | — | 122,730 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:35 pm EDT | William Dodge RueckertDirector | 40,000 | — | — | 122,730 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:34 pm EDT | Thomas C ReynoldsDirector | 40,000 | — | — | 121,049 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:33 pm EDT | Nicholas GloverDirector | 40,000 | — | — | 118,793 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:32 pm EDT | Kevan ClemensDirector | 40,000 | — | — | 112,667 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:31 pm EDT | Charles V. Baltic IIIDirector | 40,000 | — | — | 122,730 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:29 pm EDT | David M UrsoSr. V.P. and General Counsel | 130,000 | — | — | 537,500 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:27 pm EDT | Robert D. MassChief Medical Officer | 135,000 | — | — | 555,556 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:24 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 380,000 | — | — | 1,234,166 | — | |
| Jul 6, 2017 AForm 4 → | Jul 10, 2:22 pm EDT | Brian G. DrazbaChief Financial Officer | 50,000 | — | — | 200,000 | — | |
| Apr 3, 2017 AForm 4 → | Apr 4, 5:55 pm EDT | Brian G. DrazbaChief Financial Officer | 150,000 | — | — | 150,000 | — | |
| Aug 5, 2016 AForm 4 → | Aug 9, 2:48 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 102,740 | — | — | 102,740 | — | |
| Aug 5, 2016 AForm 4 → | Aug 9, 2:47 pm EDT | Robert D. MassChief Medical Officer | 51,370 | — | — | 51,370 | — | |
| Aug 5, 2016 AForm 4 → | Aug 9, 2:46 pm EDT | David M UrsoSr. V.P. and General Counsel | 51,370 | — | — | 51,370 | — | |
| Aug 5, 2016 AForm 4 → | Aug 9, 2:45 pm EDT | Thomas M. ZechChief Financial Officer | 17,123 | — | — | 17,123 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:34 pm EDT | Christine Anna WhiteDirector | 40,000 | — | — | 86,924 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:33 pm EDT | David M UrsoSr. V.P. and General Counsel | 130,000 | — | — | 407,500 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:32 pm EDT | William Dodge RueckertDirector | 40,000 | — | — | 86,924 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:31 pm EDT | Thomas C ReynoldsDirector | 40,000 | — | — | 81,049 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:29 pm EDT | Robert D. MassChief Medical Officer | 135,000 | — | — | 420,556 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:28 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 380,000 | — | — | 870,832 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:26 pm EDT | Nicholas GloverDirector | 40,000 | — | — | 78,793 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:25 pm EDT | Kevan ClemensDirector | 40,000 | — | — | 72,667 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:23 pm EDT | Leah Rush CannDirector | 40,000 | — | — | 86,924 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:20 pm EDT | Charles V. Baltic IIIDirector | 40,000 | — | — | 86,924 | — | |
| Jul 29, 2016 AForm 4 → | Aug 1, 5:18 pm EDT | Thomas M. ZechChief Financial Officer | 110,000 | — | — | 338,757 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:13 pm EDT | Christine Anna WhiteDirector | 20,000 | — | — | 46,924 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:13 pm EDT | David M UrsoSr. V.P. and General Counsel | 127,500 | — | — | 277,500 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:12 pm EDT | William Dodge RueckertDirector | 20,000 | — | — | 46,924 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:11 pm EDT | Thomas C ReynoldsDirector | 20,000 | — | — | 41,049 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:11 pm EDT | Robert D. MassChief Medical Officer | 112,500 | — | — | 315,159 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:10 pm EDT | Daniel P Gold Ph.D.Chief Executive Officer, Director | 307,500 | — | — | 490,832 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:09 pm EDT | Nicholas GloverDirector | 20,000 | — | — | 38,793 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:09 pm EDT | Kevan ClemensDirector | 20,000 | — | — | 32,667 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:07 pm EDT | Leah Rush CannDirector | 20,000 | — | — | 46,924 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:05 pm EDT | Charles V. Baltic IIIDirector | 20,000 | — | — | 46,924 | — | |
| Jul 28, 2015 AForm 4 → | Jul 29, 6:00 pm EDT | Thomas M. ZechChief Financial Officer | 90,000 | — | — | 228,757 | — | |
| Mar 24, 2015 OForm 4 → | Mar 26, 3:02 pm EDT | VIVO VENTURES VII, LLC10% Owner | 420,000 | — | — | 0 | — | |
| Mar 24, 2015 OForm 4 → | Mar 26, 3:00 pm EDT | Vivo Ventures V, LLC10% Owner | 24,401 | — | — | 0 | — |